IDEAYA Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. IDEAYA Biosciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 54% to $23,385,000. Profit margin reached -483%. Total operating expenses were $157,814,000.

Profit Margin

IDEAYA Biosciences, Inc. (NASDAQ:IDYA): Profit margin
2017 0 -11.86M
2018 0 -34.34M
2019 0 -38.44M
2020 19.53M -32.26M -165.14%
2021 27.94M -47.53M -170.11%
2022 50.93M -54.80M -107.61%
2023 23.38M -112.96M -483.05%

IDYA Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
23.38M50.93M27.94M19.53M000
Cost of revenue
4.00M2.10M1.72M39.69M1.24M0391K
Gross profit
19.37M48.83M26.21M-20.16M-1.24M0-391K
Operating exp.
Research and development
129.50M89.53M58.15M39.69M34.31M31.74M12.38M
Selling and marketing
0000000
Total operating expenses
157.81M113.43M78.20M54.88M44.27M36.41M14.43M
Operating income
-134.42M-62.50M-50.26M-35.34M-44.27M-36.41M-14.43M
Other income (expenses), net
21.46M3.84M506K849K2.29M77K2.57M
Income before tax
-112.96M-58.65M-49.76M-34.49M-41.97M-34.34M-11.86M
Income tax expense
0-3.84M-2.23M-2.23M-3.53M2.07M-150K
Net income
-112.96M-54.80M-47.53M-32.26M-38.44M-34.34M-11.86M
Earnings per share
Basic EPS
-1.96-1.32-1.35-1.31-1.9-2.41-0.83
Diluted EPS
-1.96-1.32-1.35-1.31-1.9-2.41-0.83
Data sourceData sourceData sourceData sourceData source